AC Immune SA (ACIU)
3.40
-0.11
(-3.13%)
USD |
NASDAQ |
May 16, 16:00
3.40
0.00 (0.00%)
After-Hours: 20:00
AC Immune Price: 3.40 for May 16, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 15, 2024 | 3.58 | 3.71 | 3.39 | 3.51 | 1.003M |
May 14, 2024 | 3.17 | 3.72 | 3.17 | 3.58 | 3.736M |
May 13, 2024 | 3.38 | 3.47 | 2.88 | 3.30 | 32.12M |
May 10, 2024 | 2.35 | 2.40 | 2.29 | 2.31 | 150715.0 |
May 09, 2024 | 2.32 | 2.39 | 2.32 | 2.35 | 51490.00 |
May 08, 2024 | 2.38 | 2.50 | 2.31 | 2.35 | 138042.0 |
May 07, 2024 | 2.45 | 2.45 | 2.37 | 2.38 | 148266.0 |
May 06, 2024 | 2.45 | 2.48 | 2.35 | 2.40 | 291802.0 |
May 03, 2024 | 2.43 | 2.45 | 2.37 | 2.39 | 390454.0 |
May 02, 2024 | 2.50 | 2.565 | 2.34 | 2.44 | 124878.0 |
May 01, 2024 | 2.47 | 2.526 | 2.47 | 2.50 | 60755.00 |
Apr 30, 2024 | 2.36 | 2.50 | 2.30 | 2.48 | 110000.0 |
Apr 29, 2024 | 2.40 | 2.489 | 2.37 | 2.40 | 99688.00 |
Apr 26, 2024 | 2.30 | 2.495 | 2.25 | 2.35 | 107791.0 |
Apr 25, 2024 | 2.35 | 2.40 | 2.27 | 2.29 | 160428.0 |
Apr 24, 2024 | 2.40 | 2.47 | 2.33 | 2.37 | 322914.0 |
Apr 23, 2024 | 2.45 | 2.51 | 2.37 | 2.38 | 189610.0 |
Apr 22, 2024 | 2.39 | 2.51 | 2.355 | 2.42 | 208131.0 |
Apr 19, 2024 | 2.40 | 2.49 | 2.311 | 2.36 | 316801.0 |
Apr 18, 2024 | 2.41 | 2.49 | 2.36 | 2.38 | 369340.0 |
Apr 17, 2024 | 2.45 | 2.69 | 2.42 | 2.42 | 250553.0 |
Apr 16, 2024 | 2.49 | 2.54 | 2.45 | 2.45 | 168401.0 |
Apr 15, 2024 | 2.73 | 2.799 | 2.49 | 2.52 | 113095.0 |
Apr 12, 2024 | 2.76 | 2.77 | 2.69 | 2.74 | 39028.00 |
Apr 11, 2024 | 2.79 | 3.02 | 2.71 | 2.73 | 124110.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.72
Minimum
Dec 22 2022
9.89
Maximum
Jan 15 2020
4.911
Average
4.88
Median
Sep 30 2020
Price Benchmarks
CRISPR Therapeutics AG | 55.63 |
Addex Therapeutics Ltd | 8.77 |
NLS Pharmaceutics Ltd | 0.155 |
Molecular Partners AG | 3.71 |
MoonLake Immunotherapeutics | 40.85 |
Price Related Metrics
Price to Book Value | 2.097 |
Earnings Yield | -20.26% |
Market Cap | 336.26M |